SCHEMBL4193201

SCHEMBL4193201

O=C1CCCC[C@H]1Cc1ccc(O)c(O)c1

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 10/20 0.49
PTGS1 P23219 8/20 0.49
CA1 P00915 2/20 0.49
CA2 P00918 2/20 0.49
CA4 P22748 2/20 0.49
CA6 P23280 2/20 0.49
OPRK1 P41145 1/20 0.49
HTT P42858 1/20 0.49
KMT2A Q03164 1/20 0.49
ERCC1 P07992 2/20 0.47
ERCC4 Q92889 2/20 0.47
CYP19A1 P11511 1/20 0.47
ADRA1D P25100 3/20 0.43
ADRA1A P35348 3/20 0.43
ADRA1B P35368 3/20 0.43
GAA P10253 1/20 0.43
ALPG P10696 1/20 0.43
GFER P55789 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6225548 1.00 PTGS2 (0.49) PTGS2PTGS1CA1CA2CA4
SCHEMBL11797046 0.98 CA1 (0.50) PTGS2PTGS1CA1CA2CA4
SCHEMBL107200 0.83 CYP19A1 (0.49) CA1CA2CA4CA6KMT2A
SCHEMBL28060653 0.83 CA1 (0.65) CA1CA2CA4CA6KMT2A
SCHEMBL13508150 0.81 CA1 (0.52) PTGS2PTGS1CA1CA2CA4
SCHEMBL7866022 0.81 ESR1 (0.58) PTGS2PTGS1CA1CA2CA4
SCHEMBL11794580 0.80 ESR1 (0.56) PTGS2PTGS1CA1CA2CA4
SCHEMBL27604648 0.78 PTGS2 (0.60) PTGS2PTGS1CA1CA2CA4
SCHEMBL11792466 0.77 CA1 (0.48) PTGS2PTGS1CA1CA2CA4
SCHEMBL11792405 0.76 PTGS2 (0.55) PTGS2PTGS1CA1CA2CA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009017848-A9 COMPOUNDS, COMPOSITIONS, AND METHODS FOR THE TREATMENT OF AMYLOID DISEASES SUCH AS SYSTEMIC AA AMYLOIDOSIS PROTEO TECH INC (US) 2009-04-30 WO disclosed
WO-2009017848-A1 COMPOUNDS, COMPOSITIONS, AND METHODS FOR THE TREATMENT OF AMYLOID DISEASES SUCH AS SYSTEMIC AA AMYLOIDOSIS PROTEO TECH INC. (US) 2009-02-05 WO disclosed